National Cancer Institute U.S. National Institutes of Health | www.cancer.gov
U.S. National Institute of Health www.cancer.gov

Bibliography

  1. Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009;27:1250-6.
  2. Upton B, Chu Q, Li BD. Li-Fraumeni syndrome: The genetics and treatment considerations for the sarcoma and associated neoplasms. Surg Oncol Clin N Am 2009;18:145-56.
  3. Tabori U, Malkin D. Risk stratification in cancer predisposition syndromes: Lessons learned from novel molecular developments in Li-Fraumeni Syndrome. Cancer Res 2008;68:2053-7.
  4. Wong P, Verselis SJ, Garber JE, Schneider K, DiGianni L, Stockwell DH, Li FP, Syngal S. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterol 2006;130:73-9.
  5. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005 Jun 1;103(11):2391-6.
  6. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003;63:6643-50.
  7. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002 Jun;19(6):607-14.
  8. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-7.
  9. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-11.
  10. Eng C, Schneider K, Fraumeni JF, Li FP. Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. Cancer Epidemiol Biomarkers Prev 1997;6:379-83.
  11. Li FP, Fraumeni JF Jr. Collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome. Cancer Epidemiol Biomarkers Prev 1994 Dec;3(8):715-7.
  12. Li FP, Correa P, Fraumeni JF Jr. Testing for germ line p53 mutations in cancer families. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec;1(1):91-4. (Erratum in: Cancer Epidemiol Biomarkers Prev 1992 May-Jun;1(4):335.)
  13. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP. Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 1991;51:6094-7.
  14. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990 Nov 30;250(4985):1233-8. (Erratum in: Science 1993 Feb 12;259(5097):878.)
  15. Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-62.
  16. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome? Ann Intern Med 1969;71:747-52.